Study to Validate Simple Acute Coronary Syndrome Score (SACS Score)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00947804|
Recruitment Status : Unknown
Verified December 2012 by Wayne Ruppert, St. Joseph's Hospital, Florida.
Recruitment status was: Enrolling by invitation
First Posted : July 28, 2009
Last Update Posted : April 8, 2013
The Simple Acute Coronary Syndrome (SACS) Score was developed as a Risk Stratification Tool for Acute Coronary Syndrome (ACS). It is a tool which rates a patient's: SYMPTOMS, EKG FINDINGS, RISK FACTOR PROFILE, and CARDIAC MARKERS on a scale of zero to six.
The purpose of this study is to validate the SACS Scoring tool by establishing a correlation between the score's numerical values and the degree of obstructive cardiovascular disease visualized during cardiac catheterization.
|Condition or disease|
|Acute Coronary Syndrome|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Phase 1 - Pilot Study to Validate the Simple Acute Coronary Syndrome Score; an Acute Coronary Syndrome (ACS) Risk Stratification Tool|
|Study Start Date :||August 2009|
|Estimated Primary Completion Date :||December 2013|
|Estimated Study Completion Date :||June 2014|
1. Patients with symptoms of ACS
Patients whom present emergently to the Cardiac Catheterization Lab with current symptoms of Acute Coronary Syndrome (ACS), whom at the time of admission to the cardiac catheterization lab are believed to be suffering from STEMI, NSTEMI, or Unstable Angina, with the possible need for emergency Percutaneous Coronary Intervention (PCI), or Coronary Artery Bypass Grafting (CABG).
2. Patients without symptoms of ACS
Non-emergency patients presenting to the Cardiac Catheterization Lab for elective coronary angiography, and possible PCI. These are patients whom may have experienced typical or atypical ACS symptoms intermittently, and have elected to have cardiac catheterization to rule out obstructive CAD. Patients in this group will be selected randomly, with consent obtained, prior to cardiac catheterization.
- PRESENCE or ABSENCE of obstructive CAD as discovered during non-investigative coronary angiography in the Cardiac Catheterization Lab. [ Time Frame: Within 24 hours of: a) arrival in Emergency Department, or b) admission to the hospital ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00947804
|United States, Florida|
|St. Joseph's Hospital|
|Tampa, Florida, United States, 33607|
|Principal Investigator:||Wayne W Ruppert, CVT||St. Joseph's Hospital, Tampa, FL|
|Study Director:||Humberto Coto, MD, FACC||St. Joseph's Hostpial, Tampa, Florida|
|Study Director:||Xavier E Prida, MD, FACC||St. Joseph's Hospital, Tampa, Florida|
|Study Director:||Charles Sand, MD, FACEP||St. Joesph's Hospital, Tampa, FL|